A whistleblower lawsuit has resulted in Johnson & Johnson subsidiary Acclarent paying $18 million to settle federal claims that it illegally marketed a drug delivery system without FDA approval.
Tag Archives: Acclarent
More Top Stories
Plaintiffs filing Tepezza hearing loss lawsuits claim Horizon Therapeutics, the manufacturer, knew for years that the thyroid eye disease was linked to widespread reports of hearing problems.
The U.S. government has outlined requirements for qualifying for Camp Lejeune elective option settlement offers.
A $479 million Philips CPAP class action settlement agreement will resolve claims of economic loss filed by users of the recalled devices.